Among the nation’s largest providers of monoclonal antibodies for Covid-19, Houston Methodist has infused nearly 4,000 patients. The hospital system was able to quickly ramp up its program by leveraging numerous resources through...
1-Apr-2021 2:45 PM EDT Add to Favorites
Houston Methodist infectious disease pathologists have discovered new COVID-19 cases caused by the SARS-CoV-2 UK B.1.1.7 variant are doubling weekly. By mid-March the number increased sharply to 648 cases from 305 just a week earlier. The findings...
31-Mar-2021 6:00 PM EDT Add to Favorites
Houston Methodist finds multiple cases of significant coronavirus mutations, including Brazil strain
Houston Methodist has sequenced more than 20,000 of Houston’s coronavirus genomes since the start of the pandemic and leads the SARS-CoV-2 genome sequencing efforts in the U.S. In the most recent batches of genomes, the U.K., South Africa, Brazil,...
2-Mar-2021 3:05 PM EST Add to Favorites
A new Houston Methodist study found males are more likely to test positive for COVID-19, have complications and die from the virus than females, independent of age. The peer-reviewed observational study appears in PLOS ONE, a multidisciplinary...
15-Jan-2021 8:20 AM EST Add to Favorites
Diego Martin, M.D., Ph.D., has joined Houston Methodist Hospital as Chair of the Department of Radiology.
2-Dec-2020 10:35 AM EST Add to Favorites
A husband and wife, a mother and son, two cousins, two sisters, and a boss and her direct report were strangers from different cities and diverse backgrounds. Now, after a successful, and rare, 5-way kidney swap at Houston Methodist, they are...
27-Oct-2020 3:05 PM EDT Add to Favorites
Houston Methodist using 3D technology, artificial intelligence and more in new breast cancer research studies
Trials include a model to create custom breast implants, a smarter method to recommend biopsy, a novel approach to preserve sensation in implant-based breast reconstruction, and a new clinical trial investigating a modified herpes virus as a tactic...
8-Oct-2020 2:05 PM EDT Add to Favorites
60-day follow-up of 300+ COVID-19 patients demonstrates convalescent plasma therapy is safe and effective
A follow-up Houston Methodist study of 351 COVID-19 patients treated with convalescent plasma therapy concludes those patients receiving convalescent plasma with a very high antibody content – or high titer – within 72 hours of hospitalization...
6-Oct-2020 3:05 PM EDT Add to Favorites
See All News
24-Feb-2021 10:10 AM EST
A silver lining is emerging amid the COVID-19 pandemic. Influenza numbers are way down – 98 percent down, according to the CDC. Locally, during flu season last year, Houston Methodist’s system of eight hospitals saw 250 to 450 flu cases per...
2-Feb-2021 2:30 PM EST
Principal Investigator for COVID-19 drug with FDA Emergency Use Authorization available to speak on limited government supply of drug and pending clinical trials
17-Nov-2020 1:05 PM EST
16-Nov-2020 10:40 AM EST
Houston Methodist oncologist available to comment on NCI model predicting 10,000 additional breast/colorectal cancer deaths due to COVID-19
24-Jun-2020 10:10 AM EDT
Necessity being the mother of invention, Houston Methodist clinicians, researchers and staff have collaborated on a number of clinical device and research innovations in response to COVID-19. Houston Methodist Academic Institute leadership has...
29-Apr-2020 12:10 PM EDT
Bita Kash, PhD, Researcher with Houston Methodist, available to discuss COVID-19 and African American communities
20-Apr-2020 2:30 PM EDT
8-Jan-2020 3:00 PM ESTSee All Experts